Increasing Accessibility of Regenerative Medicine Through Innovative Solutions

点击翻译按钮获取中文摘要

I have established an accessible form of cell therapy that is safe even in premature babies with chronic lung disease. I will extend on my research by working with key industry partners to develop processes for the manufacture of regenerative medicines at a low cost and highly efficient manner. This will expedite patient access to potentially life-saving treatments. These cells will be used in five clinical trials in adults and extremely premature babies across three Australian hospitals.